| 1 |
El-Shial EM, Kabbash A, El-Aasr M, El-Feky OA, El-Sherbeni SA. Elucidation of Natural Components of Gardenia thunbergia Thunb. Leaves: Effect of Methanol Extract and Rutin on Non-Alcoholic Fatty Liver Disease. Molecules 2023;28. [PMID: 36677937 DOI: 10.3390/molecules28020879] [Reference Citation Analysis]
|
| 2 |
Oh KK, Gupta H, Min BH, Ganesan R, Sharma SP, Won SM, Jeong JJ, Lee SB, Cha MG, Kwon GH, Jeong MK, Hyun JY, Eom JA, Park HJ, Yoon SJ, Choi MR, Kim DJ, Suk KT. The identification of metabolites from gut microbiota in NAFLD via network pharmacology. Sci Rep 2023;13:724. [PMID: 36639568 DOI: 10.1038/s41598-023-27885-w] [Reference Citation Analysis]
|
| 3 |
Shatta MA, El-derany MO, Gibriel AA, El-mesallamy HO. Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04619-6] [Reference Citation Analysis]
|
| 4 |
Chen M, Zhang F, Chen B, Lau C, Xu K, Tong T, Huo C, Han Q, Su T, Kwan HY. Omics approach to reveal the effects of obesity on the protein profiles of the exosomes derived from different adipose depots. Cell Mol Life Sci 2022;79:570. [DOI: 10.1007/s00018-022-04597-4] [Reference Citation Analysis]
|
| 5 |
Gallego-durán R, Albillos A, Ampuero J, Arechederra M, Bañares R, Blas-garcía A, Berná G, Caparrós E, Delgado TC, Falcón-pérez JM, Francés R, Fernández-barrena MG, Graupera I, Iruzubieta P, Nevzorova YA, Nogueiras R, Macías RI, Martín F, Sabio G, Soriano G, Vaquero J, Cubero FJ, Gracia-sancho J. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH). Gastroenterología y Hepatología (English Edition) 2022;45:724-734. [DOI: 10.1016/j.gastre.2022.02.004] [Reference Citation Analysis]
|
| 6 |
Sharma N, Shaikh TB, Eedara A, Kuncha M, Sistla R, Andugulapati SB. Dehydrozingerone ameliorates thioacetamide-induced liver fibrosis via inhibition of hepatic stellate cells activation through modulation of the MAPK pathway. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.175366] [Reference Citation Analysis]
|
| 7 |
Min RWM, Aung FWM, Liu B, Arya A, Win S. Mechanism and Therapeutic Targets of c-Jun-N-Terminal Kinases Activation in Nonalcoholic Fatty Liver Disease. Biomedicines 2022;10:2035. [DOI: 10.3390/biomedicines10082035] [Reference Citation Analysis]
|
| 8 |
Bathish B, Robertson H, Dillon JF, Dinkova-Kostova AT, Hayes JD. Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2. Free Radic Biol Med 2022;188:221-61. [PMID: 35728768 DOI: 10.1016/j.freeradbiomed.2022.06.226] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 9 |
Heng CM, Gilad N, Darlyuk-saadon I, Wong WF, Engelberg D. Targeting the p38α pathway in chronic inflammatory diseases: Could activation, not inhibition, be the appropriate therapeutic strategy? Pharmacology & Therapeutics 2022;235:108153. [DOI: 10.1016/j.pharmthera.2022.108153] [Reference Citation Analysis]
|
| 10 |
Jiang ZY, Zhou Y, Zhou L, Li SW, Wang BM. Identification of Key Genes and Immune Infiltrate in Nonalcoholic Steatohepatitis: A Bioinformatic Analysis. Biomed Res Int 2021;2021:7561645. [PMID: 34552988 DOI: 10.1155/2021/7561645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Crespo M, Leiva M, Sabio G. Circadian Clock and Liver Cancer. Cancers (Basel) 2021;13:3631. [PMID: 34298842 DOI: 10.3390/cancers13143631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
